HAEMONETICS CORP (HAE) competitors & alternatives
Health Care · NYSE
HAEMONETICS CORP (HAE)'s top competitors and alternatives — its most similar public companies — include Becton Dickinson (BDX), PAYSIGN INC (PAYS), ADMA BIOLOGICS INC (ADMA), CERUS CORP (CERS), Penumbra, Inc. (PEN), Apyx Medical Corp (APYX), ORASURE TECHNOLOGIES INC (OSUR), QUIDELORTHO CORP (QDEL), INTEGER HOLDINGS CORP (ITGR), LEMAITRE VASCULAR INC (LMAT), EMBECTA CORP (EMBC) and Abbott Laboratories (ABT). These are HAEMONETICS CORP's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top HAE competitors & alternatives
-
Becton DickinsonBDXHealth Care
BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and…
$153.16 (as of 2026-07-22) · market cap $42.2B
-
PAYSIGN INCPAYSFinancials
Paysign operates a vertically integrated fintech platform delivering prepaid card solutions and processing services to corporate, consumer, and government…
$8.96 (as of 2026-07-22) · market cap $497M
-
ADMA BIOLOGICS INCADMAHealth Care
ADMA manufactures and markets FDA-approved plasma-derived immune globulin products for immunodeficient and infectious disease patients, operating an integrated…
$8.38 (as of 2026-07-22) · market cap $2.0B
-
CERUS CORPCERSHealth Care
Cerus develops pathogen-inactivation technologies for blood transfusions and cellular therapy products, with the INTERCEPT Blood System as its lead commercial…
$3.02 (as of 2026-07-22) · market cap $625M
-
Penumbra, Inc.PENHealth Care
The world's leading mechanical thrombectomy company enabling rapid, minimally invasive blood clot removal across ischemic stroke, pulmonary embolism, and limb…
$316.50 (as of 2026-07-22) · market cap $12.4B
-
Apyx Medical CorpAPYXHealth Care
Apyx Medical provides advanced helium plasma-based surgical technology for cosmetic body contouring and hospital-based electrosurgical procedures.
$3.91 (as of 2026-07-22) · market cap $163M
-
ORASURE TECHNOLOGIES INCOSURHealth Care
OrasuRe is a diagnostic company specializing in rapid point-of-care and self-test solutions for infectious diseases and rare conditions, with recent expansion…
$3.79 (as of 2026-07-22) · market cap $262M
-
QUIDELORTHO CORPQDELHealth Care
Global diagnostics company providing immunoassay, molecular testing, clinical chemistry, and transfusion medicine solutions across labs, point-of-care, and…
$16.68 (as of 2026-07-22) · market cap $1.1B
-
INTEGER HOLDINGS CORPITGRHealth Care
Integer Holdings is a pure-play medical device CDMO specializing in high-precision cardio-vascular, cardiac rhythm, and neuromodulation components and finished…
$96.56 (as of 2026-07-22) · market cap $3.3B
-
LEMAITRE VASCULAR INCLMATHealth Care
LeMaitre Vascular develops specialized medical devices and tissue-based solutions for vascular and cardiovascular surgery, targeting an aging population with…
$98.81 (as of 2026-07-22) · market cap $2.3B
-
EMBECTA CORPEMBCHealth Care
A dedicated diabetes care company specializing in insulin delivery systems and pen needles for millions of users worldwide.
$3.25 (as of 2026-07-22) · market cap $193M
-
Abbott LaboratoriesABTHealth Care
Abbott Laboratories is a diversified healthcare giant providing a broad portfolio of diagnostic systems, medical devices, nutritional products, and established…
$100.57 (as of 2026-07-22) · market cap $175.1B
Not quite? Describe exactly what you want →
Peers are HAEMONETICS CORP's closest public companies by shared sub-industry, sector and business themes. See the full profile: HAEMONETICS CORP (HAE).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.